EXPERIENCE OF SCALP COOLING FOR PREVENTION CHEMOTHERAPY-INDUCED HAIR LOSS
https://doi.org/10.21294/1814-4861-2017-16-2-66-70
Abstract
Short-term results of using Orbis II Paxman device for prevention of chemotherapy-induced alopecia were analyzed. A total of 98 sessions of scalp cooling were performed in 32 patients. Twenty-four (80 %) scalpcooled patients had good hair preservation. The level of comfort during the procedure was 87 %. Patients with breast cancer underwent 55 scalp cooling sessions. Good hair preservation was observed in 88% of cases. Grade 1 and 2 alopecia was observed in 12% of patients. Thus, the data obtained confirm that the use of scalp cooling methods can improve the quality of life for patients receiving chemotherapy.
About the Authors
I. S. Polezhaeva
Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation
Russian Federation
Polezhaeva Irina S. - MD, Physician, Radiology Department, Cancer Research Institute.
5, Kooperativny Street, 634050-Tomsk. E-mail: ispolezhaeva@gmail.com. SPIN-code: 4849-3856Zh. A. Starceva
Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences; National Research Tomsk Polytechnic University
Russian Federation
Russian Federation
Startseva Zhanna A. - MD, DSc, Head of Radiology Department, Cancer Research Institute.
5, Kooperativny Street, 634050-Tomsk; 30, Lenina avenue, 634050-TomskE-mail: zhanna.alex@rambler.ru. SPIN-code: 8121-0310V. E. Goldberg
Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation
Russian Federation
Goldberg Viktor E. - MD, DSc, Professor, Head of Chemotherapy Department, Cancer Research Institute.
5, Kooperativny Street, 634050-Tomsk. E-mail: goldbergve@mail.ru. SPIN-code: 7587-0560
N. O. Popova
Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation
Russian Federation
Popova Natalia O. - MD, PhD, Senior Researcher, Chemotherapy Department, Cancer Research Institute.
5, Kooperativny Street, 634050-Tomsk. E-mail: popova75tomsk@mail.ru. SPIN-код: 7672-1029
References
1. Khrichkova T.Yu., Goldberg V.E., Zhdanov V.V., Popov D.N., Tuzikov S.A., Afanasyev S.G., Dygai A.M. Mechanisms of hematological toxicity of Cisplatin and Xeloda in the conditions of combined therapy of the patients with metastatic gastric cancer. Siberian Scientific Medical Journal. 2005; 4 (118): 64–68. [in Russian]
2. Auvinen P.K., Mahonen U.A., Soininen K.M., Paananen P.K., Ranta-Koponen P.H., Saavalainen I.E., Johansson R.T. The effectiveness of a scalp cooling cap in preventing chemotherapyinduced alopecia. Tumori. 2010; 96 (2): 271–275.
3. Breed W.P., van den Hurk C.J., Peerbooms M. Presentation, Impact and Prevention of Chemotherapy-induced Hair Loss. Expert Rev Dermatol. 2011; 6 (1): 109–125.
4. van den Hurk C.J., Mols F., Vingerhoets A.J., Breed W.P. Impact of alopecia and scalp cooling on the well-being of breast cancer patients. Psycho-oncology. 2010; 19 (7): 701–709. doi: 10.1002/pon.1615.
5. van den Hurk C.J., Peerbooms M., van de Poll-Franse L.V., Nortier J.W., Coebergh J.W., Breed W.P. Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients – Results of the Dutch Scalp Cooling Registry. Oncologica. 2012; 51: 497–504. doi: 10.3109/0284186X.2012.658966.
6. UK Study of Efficacy. Paxman [Internet] [cited 06.06.2016]. Available from: http://paxmanscalpcooling.com.
Review
For citations:
Polezhaeva I.S., Starceva Zh.A., Goldberg V.E., Popova N.O. EXPERIENCE OF SCALP COOLING FOR PREVENTION CHEMOTHERAPY-INDUCED HAIR LOSS. Siberian journal of oncology. 2017;16(2):66-70. (In Russ.) https://doi.org/10.21294/1814-4861-2017-16-2-66-70
Views:
1295
Email this article 
